Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.97 USD | -1.83% | +0.50% | +1.67% |
05-08 | Syndax Pharmaceuticals Q1 Net Loss Widens | MT |
05-08 | Transcript : Syndax Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.67% | 1.9B | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- SNDX Stock
- News Syndax Pharmaceuticals, Inc.
- Correction: Syndax Pharmaceuticals Prices Public Offering at $18.50 per Share